LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure for emerging markets, announced on May 22, 2026, continued progress in developing its mobile healthcare application ecosystem, including applications being readied for the Apple App Store and Google Play Store.
The company reported that it has surpassed 1,000 early-stage platform subscribers, a milestone that management believes reflects growing interest in its healthcare technology ecosystem. The applications under development aim to support telehealth, healthcare communication, patient engagement, provider coordination, emergency response, and AI-assisted healthcare initiatives as part of LataMed's broader digital healthcare infrastructure strategy.
Management stated that the company is continuing development, testing, integration, and platform optimization for multiple mobile healthcare applications intended to improve healthcare accessibility in emerging markets, particularly Latin America. Certain applications are being prepared for submission to Apple and Google app stores after further development, internal testing, platform review, and regulatory considerations.
Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., commented: “We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives.”
The company emphasized that the applications and platform technologies remain under active development and are not yet fully commercialized or broadly deployed. No assurance can be given regarding the timing of public release, app store availability, regulatory progression, or operational success.
LataMed AI's technology initiatives are focused on scalable healthcare infrastructure solutions for underserved and developing markets where access to healthcare coordination, telehealth services, and digital tools may be limited. The company believes continued user engagement will provide valuable operational feedback as development progresses.
For more information, visit https://latamed.ai or review the company's SEC filings at www.sec.gov.
